PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Sarcoidosis D012507 13 associated lipids
Pleurisy D010998 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cataract D002386 34 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Sarcoma 180 D012510 21 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Hyperemia D006940 25 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Peritonitis D010538 38 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Ascariasis D001196 3 associated lipids
Thyroid Diseases D013959 8 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Brain Ischemia D002545 89 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Astrocytoma D001254 15 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Nasal Polyps D009298 26 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Erythema D004890 22 associated lipids
Hyperalgesia D006930 42 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Spasm D001986 18 associated lipids
Hyperlipidemias D006949 73 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cough D003371 19 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Rossi AG and O'Flaherty JT Prostaglandin binding sites in human polymorphonuclear neutrophils. 1989 Prostaglandins pmid:2549574
Kerr JS et al. Effects of recombinant interleukin-1 beta on phospholipase A2 activity, phospholipase A2 mRNA levels, and eicosanoid formation in rabbit chondrocytes. 1989 Biochem. Biophys. Res. Commun. pmid:2558648
Kawabe Y et al. Genesis and recovery of ethanol-induced gastric lesions in rats: possible involvement of prostaglandin D2. 1989 Am. J. Gastroenterol. pmid:2916522
Sakai T et al. Protection by cycloheximide against cytotoxicity induced by vincristine, colchicine, or delta 12-prostaglandin J2 on human osteosarcoma cells. 1989 Cancer Res. pmid:2917351
Phillips GD and Holgate ST Interaction of inhaled LTC4 with histamine and PGD2 on airway caliber in asthma. 1989 J. Appl. Physiol. pmid:2917934
Ban M et al. A flavonoid inhibitor of 5-lipoxygenase inhibits leukotriene production following ischemia in gerbil brain. 1989 Stroke pmid:2919414
Ohuchi K et al. Stimulation of histamine release and arachidonic acid metabolism in rat peritoneal mast cells by thapsigargin, a non-TPA-type tumor promoter. 1989 Biochim. Biophys. Acta pmid:2469475
Wolfe LS et al. Synthesis and functions of cyclooxygenase and lipoxygenase products in brain: new findings and an appraisal. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2568735
Wolfe LS and Pellerin L Arachidonic acid metabolites in the rat and human brain. New findings on the metabolism of prostaglandin D2 and lipoxygenase products. 1989 Ann. N. Y. Acad. Sci. pmid:2570544
Bhattacharya SK et al. Effect of centrally administered prostaglandin D2 and some prostaglandin synthesis inhibitors on carrageenan-induced paw oedema in rats. 1989 J. Pharm. Pharmacol. pmid:2571705
Zehr BB et al. Use of segmental airway lavage to obtain relevant mediators from the lungs of asthmatic and control subjects. 1989 Chest pmid:2539958
Benyon RC The human skin mast cell. 1989 Clin. Exp. Allergy pmid:2667702
Leynadier F [Mast cells and basophils in asthma]. 1989 Ann. Biol. Clin. (Paris) pmid:2675683
Hamid-Bloomfield S and Whittle BJ Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C. 1989 Br. J. Pharmacol. pmid:2647205
Kuiper J et al. The role of prostaglandins in endotoxin stimulated glycogenolysis in the liver. 1989 Agents Actions pmid:2653002
Amano N et al. The effect of pentobarbital and ether anesthesia on rat brain PGD2 content. 1989 Agressologie pmid:2610292
Shram SI et al. [Preparation and properties of prostaglandin D2 labelled with tritium with high molar radioactivity]. 1989 Bioorg. Khim. pmid:2590255
Yamada K [The effect of prostaglandin D2 on rat testicular testosterone levels]. 1989 Nihon Naibunpi Gakkai Zasshi pmid:2591605
Salari H and Chan-Yeung M Interleukin-1 potentiates antigen-mediated arachidonic acid metabolite formation in mast cells. 1989 Clin. Exp. Allergy pmid:2513105
Chakraborti S et al. Oxidant-mediated activation of phospholipase A2 in pulmonary endothelium. 1989 Am. J. Physiol. pmid:2514605
Trist DG et al. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase. 1989 Br. J. Pharmacol. pmid:2466517
Triggiani M et al. Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468619
Virgolini I et al. Effects of taprostene, a chemically stable prostacyclin analogue, in patients with ischaemic peripheral vascular disease: a placebo controlled double-blind trial. 1989 Prostaglandins Leukot. Essent. Fatty Acids pmid:2514430
Stürzebecher S et al. Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets. 1989 Prog. Clin. Biol. Res. pmid:2477855
Cohan VL et al. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. 1989 Am. Rev. Respir. Dis. pmid:2478059
Reshef A et al. The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR). 1989 J. Allergy Clin. Immunol. pmid:2478604
Marone G et al. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion. 1989 Life Sci. pmid:2480501
Reiss TF et al. Local mediator release after antigen challenge of a bronchial segment in allergic dogs. 1989 Am. J. Physiol. pmid:2481982
Levi-Schaffer F and Shalit M Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells activated with peptides. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2482257
Morrow JD et al. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. 1989 Prostaglandins pmid:2475889
Gray PR et al. The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves. 1989 Am. Rev. Respir. Dis. pmid:2502051
Froissart P et al. Modulation by phorbol 12-myristate 13-acetate of arachidonic acid release from rat basophilic leukemia cells stimulated with A23187. 1989 Biochim. Biophys. Acta pmid:2496761
Keenan CM and Rangachari PK Eicosanoid interactions in the canine proximal colon. 1989 Am. J. Physiol. pmid:2539737
Raisz LG and Woodiel FN Effect of alterations in the cyclopentane ring on bone resorptive activity of prostaglandin. 1989 Prostaglandins pmid:2727307
Wolfe LS et al. Metabolism of prostaglandin D2 by human cerebral cortex into 9 alpha, 11 beta-prostaglandin F2 by an active NADPH-dependent 11-ketoreductase. 1989 J. Neurochem. pmid:2723663
Rodriguez y Baena R et al. Effects of nicardipine on the ex vivo release of eicosanoids after experimental subarachnoid hemorrhage. 1989 J. Neurosurg. pmid:2585083
Marone G Control mechanisms of mediator release in human basophils and mast cells. 1988 Nov-Dec Immunol. Invest. pmid:2465995
Hayaishi O Sleep-wake regulation by prostaglandins D2 and E2. 1988 J. Biol. Chem. pmid:3049580
Tran-Thi TA et al. Net prostaglandin release by perfused rat liver after stimulation with phorbol 12-myristate 13-acetate. 1988 J. Hepatol. pmid:3166024
Parsons WG and Roberts LJ Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. 1988 J. Immunol. pmid:3139758
Kuiper J et al. The induction of glycogenolysis in the perfused liver by platelet activating factor is mediated by prostaglandin D2 from Kupffer cells. 1988 Biochem. Biophys. Res. Commun. pmid:3144970
Fukui A et al. Effects of prostaglandin D2 and omeprazole on indomethacin-induced gastric ulcers in rats. 1988 Clin. Exp. Pharmacol. Physiol. pmid:3149561
Vigano T et al. Prostaglandin synthetase inhibition and formation of lipoxygenase products in immunologically challenged normal human lung parenchyma. 1988 Eicosanoids pmid:3152489
Ujihara M et al. Biochemical and immunological demonstration of prostaglandin D2, E2, and F2 alpha formation from prostaglandin H2 by various rat glutathione S-transferase isozymes. 1988 Arch. Biochem. Biophys. pmid:3041912
Rodriguez y Baena R et al. A study on cisternal CSF levels of arachidonic acid metabolites after aneurysmal subarachnoid hemorrhage. 1988 J. Neurol. Sci. pmid:3132538
Michel L et al. Prostaglandin D2 generation in mouse bone marrow-derived mast cells exposed to dexamethasone is associated with endogenous peroxidase activity. 1988 Lab. Invest. pmid:2460694
Lebel B et al. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. 1988 J. Allergy Clin. Immunol. pmid:2461405
Bousquet J et al. Antiallergic activity of H1-receptor antagonists assessed by nasal challenge. 1988 J. Allergy Clin. Immunol. pmid:2461406
Church MM et al. The mediator and cellular basis of the allergic response. 1988 Allergy pmid:2462372
Takei M et al. Role of cyclic AMP during histamine release. Histamine release is not directly related to increase in cyclic AMP levels in rat mast cells activated by concanavalin A, anti-IgE, antigen, prostaglandin D2 and isoproterenol. 1988 Biol. Chem. Hoppe-Seyler pmid:2463844